ReNeuron Group plc
RNUGF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4,168 | $16,478 | $48,266 | $36,258 |
| - Cash | $6,153 | $9,548 | $14,703 | $12,625 |
| + Debt | $421 | $562 | $719 | $873 |
| Enterprise Value | -$1,564 | $7,492 | $34,282 | $24,506 |
| Revenue | $530 | $403 | $257 | $6,065 |
| % Growth | 31.5% | 56.8% | -95.8% | – |
| Gross Profit | -$3,933 | -$7,665 | -$9,246 | -$10,270 |
| % Margin | -742.1% | -1,902% | -3,597.7% | -169.3% |
| EBITDA | -$6,370 | -$10,709 | -$12,998 | -$13,404 |
| % Margin | -1,201.9% | -2,657.3% | -5,057.6% | -221% |
| Net Income | -$5,408 | -$9,689 | -$11,347 | -$11,412 |
| % Margin | -1,020.4% | -2,404.2% | -4,415.2% | -188.2% |
| EPS Diluted | -0.095 | -0.17 | -0.29 | -0.35 |
| % Growth | 44.3% | 41.4% | 17.1% | – |
| Operating Cash Flow | -$7,484 | -$7,411 | -$6,052 | -$14,304 |
| Capital Expenditures | -$220 | -$302 | -$25 | -$119 |
| Free Cash Flow | -$7,704 | -$7,713 | -$6,077 | -$14,423 |